Comparing the performance of dengue virus IgG and IgG-capture enzyme-linked immunosorbent assays in seroprevalence study

Comparing the performance of dengue virus IgG and IgG-capture enzyme-linked immunosorbent assays in seroprevalence study

Abstract Background Dengue virus (DENV) is the leading cause of arboviral diseases in humans worldwide. Currently Dengvaxia, the first dengue vaccine licensed in 20 countries, was recommended for DENV seropositive individuals aged 9–45 years. Studying dengue seroprevalence can improve our understand...

Full description

Bibliographic Details
Main Authors: Jih-Jin Tsai, Ching-Yi Tsai, Ping-Chang Lin, Chun-Hong Chen, Wen-Yang Tsai, Yu-Ching Dai, Yen-Chia Lin, Celia Pedroso, Carlos Brites, Wei-Kung Wang
Format: Article
Language:English
Published: BMC 2023-05-01
Series:BMC Infectious Diseases
Subjects:
Dengue virus
Seroprevalence
ELISA
IgG-capture ELISA
Online Access:https://doi.org/10.1186/s12879-023-08307-8

Internet

https://doi.org/10.1186/s12879-023-08307-8

Similar Items